Inventor

Thomas Lee Cupps

Inventor
Oxford, OH, US

Overview

22→
Patents
1991–2002
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
6,486,190'5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability'20026,436,978'Guanidinylamino heterocycle compounds useful as -2 adrenoceptor agonists'20026,423,724'7-(2-imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists'20026,399,598'Diheterocyclic metalloprotease inhibitors'20026,391,878'Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists'20026,306,877'Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists'20016,225,331'Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists'20016,172,095'Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists'20016,121,258'1,5-heterocyclic metalloprotease inhibitors'20005,916,900'7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists'19995,804,587'6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor agonists'19985,739,148'6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists'19985,716,966'7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists'19985,691,370'5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists'19975,578,607'6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists'19965,576,437'7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists'19965,541,210'5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 andrenoceptor agonists'19965,478,858'5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists'19955,461,075'Use of vanilloids for the prevention of lesions due to herpes simplex infections'19955,099,030'Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain'19925,045,565'Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain'19915,013,759'Compounds and compositions having anti-inflammatory and analgesic activity'1991

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1991–2002Patents assigned to PROCTER & GAMBLE (22)· patent assignee history
1991–2002Based in Oxford, OH, US· patent location history
1995Based in Maineville, OH, US· patent location history
2000–2002Based in Norwich, NY, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PROCTER & GAMBLE221991–2002
Locations
LocationPatentsSpan
Oxford, OH, US141991–2002
Norwich, New York, US72000–2002
Maineville, OH, US11995